Cowan Elvia

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cowan Elvia's trades of Vaxcyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
106.93
Quantity 11,431 +41.7%
Value US$2,410,301
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
228.77
Quantity 24,148 -19.2%
Value US$21,341
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
27.61
Quantity 67,668
Value US$3,833,854
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
86.74
Quantity 19,000 -40.5%
Value US$1,648,060
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
86.74
Quantity 19,000
Value US$1,648,060
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
60.00
Quantity 3,000 -9.4%
Value US$180,000
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
60.00
Quantity 3,000
Value US$180,000
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
56.26
Quantity 405 -1.4%
Value US$22,787
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
55.39
Quantity 1,487 -4.8%
Value US$82,360
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
55.89
Quantity 1,892
Value US$105,744
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
58.62
Quantity 2,500
Value US$146,550
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
58.59
Quantity 2,500 -7.5%
Value US$146,482
US Vaxcyte Inc (PCVX)
Transaction date
Sale
Price
47.94
Quantity 6,716 -31.6%
Value US$321,931
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
47.90
Quantity 4,907 -18.8%
Value US$235,040
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
47.92
Quantity 11,623
Value US$556,972
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
107.67
Quantity 5,000 -28.2%
Value US$538,350
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
107.67
Quantity 5,000
Value US$538,350
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
85.00
Quantity 5,000 -28.2%
Value US$425,000
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
85.00
Quantity 5,000
Value US$425,000
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
80.00
Quantity 5,000 -28.2%
Value US$400,000
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
80.00
Quantity 5,000
Value US$400,000
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
74.90
Quantity 4,901 -28.2%
Value US$367,085
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
73.69
Quantity 4,455 -20.4%
Value US$328,284
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
73.08
Quantity 2,322 -9.6%
Value US$169,701
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
74.57
Quantity 11,678
Value US$870,828
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-04 2026-11-02
US Vaxcyte Inc (PCVX)
PlS Planned sale
11,431 +41.7%
106.93
US$2,410,301 		11,431 +41.7% 106.93 US$2,410,301
2026-11-04 2026-11-02
US Vaxcyte Inc (PCVX)
PlS Planned sale
24,148 -19.2%
228.77
US$21,341 		24,148 -19.2% 228.77 US$21,341
2026-11-02 2026-11-02
US Vaxcyte Inc (PCVX)
PrS Proposed sale
67,668
27.61
US$3,833,854 		67,668 27.61 US$3,833,854
2026-10-07 2026-10-05
US Vaxcyte Inc (PCVX)
PlS Planned sale
19,000 -40.5%
86.74
US$1,648,060 		19,000 -40.5% 86.74 US$1,648,060
2026-10-05 2026-10-05
US Vaxcyte Inc (PCVX)
PrS Proposed sale
19,000
86.74
US$1,648,060 		19,000 86.74 US$1,648,060
2026-04-08 2026-04-07
US Vaxcyte Inc (PCVX)
PlS Planned sale
3,000 -9.4%
60.00
US$180,000 		3,000 -9.4% 60.00 US$180,000
2026-04-07 2026-04-07
US Vaxcyte Inc (PCVX)
PrS Proposed sale
3,000
60.00
US$180,000 		3,000 60.00 US$180,000
2026-03-18 2026-03-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
405 -1.4%
56.26
US$22,787 		405 -1.4% 56.26 US$22,787
2026-03-18 2026-03-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,487 -4.8%
55.39
US$82,360 		1,487 -4.8% 55.39 US$82,360
2026-03-17 2026-03-17
US Vaxcyte Inc (PCVX)
PrS Proposed sale
1,892
55.89
US$105,744 		1,892 55.89 US$105,744
2026-03-11 2026-03-11
US Vaxcyte Inc (PCVX)
PrS Proposed sale
2,500
58.62
US$146,550 		2,500 58.62 US$146,550
2026-03-11 2026-03-11
US Vaxcyte Inc (PCVX)
PlS Planned sale
2,500 -7.5%
58.59
US$146,482 		2,500 -7.5% 58.59 US$146,482
2025-12-29 2025-12-23
US Vaxcyte Inc (PCVX)
S Sale
6,716 -31.6%
47.94
US$321,931 		6,716 -31.6% 47.94 US$321,931
2025-12-29 2025-12-23
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,907 -18.8%
47.90
US$235,040 		4,907 -18.8% 47.90 US$235,040
2025-12-23 2025-12-23
US Vaxcyte Inc (PCVX)
PrS Proposed sale
11,623
47.92
US$556,972 		11,623 47.92 US$556,972
2024-09-05 2024-09-03
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -28.2%
107.67
US$538,350 		5,000 -28.2% 107.67 US$538,350
2024-09-03 2024-09-03
US Vaxcyte Inc (PCVX)
PrS Proposed sale
5,000
107.67
US$538,350 		5,000 107.67 US$538,350
2024-07-17 2024-07-16
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -28.2%
85.00
US$425,000 		5,000 -28.2% 85.00 US$425,000
2024-07-16 2024-07-16
US Vaxcyte Inc (PCVX)
PrS Proposed sale
5,000
85.00
US$425,000 		5,000 85.00 US$425,000
2024-07-09 2024-07-08
US Vaxcyte Inc (PCVX)
PlS Planned sale
5,000 -28.2%
80.00
US$400,000 		5,000 -28.2% 80.00 US$400,000
2024-07-08 2024-07-08
US Vaxcyte Inc (PCVX)
PrS Proposed sale
5,000
80.00
US$400,000 		5,000 80.00 US$400,000
2024-03-04 2024-03-01
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,901 -28.2%
74.90
US$367,085 		4,901 -28.2% 74.90 US$367,085
2024-03-04 2024-03-01
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,455 -20.4%
73.69
US$328,284 		4,455 -20.4% 73.69 US$328,284
2024-03-04 2024-03-01
US Vaxcyte Inc (PCVX)
PlS Planned sale
2,322 -9.6%
73.08
US$169,701 		2,322 -9.6% 73.08 US$169,701
2024-03-01 2024-03-01
US Vaxcyte Inc (PCVX)
PrS Proposed sale
11,678
74.57
US$870,828 		11,678 74.57 US$870,828